Aphranel® Showcases Regenerative Aesthetics at 2026 MXGP Shanghai Event

In a significant collaboration, aphranel®, a pioneering brand in regenerative aesthetics developed by MOYOM Biotech in China, aligned with the prestigious FIM Motocross World Championship (MXGP) 2026 held in Shanghai from September 11 to 13. This strategic partnership not only highlights aphranel®'s commitment to innovation but also promotes its cutting-edge approach to facial aesthetics to a diverse audience beyond just medical professionals.

The aphranel® booth at MXGP Shanghai drew significant attention, attracting visitors from both the motorsport community and the broader lifestyle sphere with its unique and visually striking design. The installation showcased a synergy between racing and contemporary aesthetics, further amplified by engaging displays of motorcycles and motocross gear. Visitors were invited to immerse themselves in the aphranel® experience, capturing memorable moments while posing for photos alongside the motorcycle exhibit.

The aphranel® area featured a signature green color scheme paired with a stunning butterfly installation, harmonizing with the motorbikes and motocross displays. Attendees were also encouraged to take a break at the "aphranel Time Café," which became a hotspot for social media photography, all under the theme, "Own Your State. Dare to Take the Stage." This thematic focus resonated particularly well with the predominantly male audience at the event, showcasing aphranel®'s dedication to male facial aesthetics.

The brand's flagship product, the "MagiCCrystal CaHA Biostructurer," was highlighted for its anatomical approach in facial contouring, specifically targeting areas such as the forehead, nose, chin, and jawline. This technique emphasizes the importance of facial proportions and structural definition while ensuring that the unique features of each individual are preserved. The breakthrough product emerged from a decade-long research initiative, garnering NMPA Class III medical device approval in February 2025, making it the first of its kind in China that employs calcium hydroxylapatite microspheres for facial biostructuring.

Zhang Xue, founder of the Chinese motorcycle brand ZXMOTO, also visited the aphranel® booth, exemplifying the intersection of different industries and the collaborative spirit brought forth by this event. With over 200,000 syringes sold and availability in more than 700 aesthetic clinics across China, the success of the MagiCCrystal product underscores the growing popularity and application of advanced aesthetic solutions.

The partnership at MXGP allowed aphranel® to merge its foundational values—long-term research, technical accuracy, resilience, and stringent standards in biomaterials—with the high-performance characteristics typically celebrated in motorsport. This unique endeavor aligns with aphranel®'s broader aspirations to introduce its regenerative aesthetics technology to international audiences.

Following the event in Shanghai, aphranel® intends to advance its global expansion efforts, embodying its philosophy of “Be With Time,” which effectively marries the company’s scientific endeavors with evolving perceptions of contemporary aesthetics. As it continues to push the boundaries of aesthetic innovation, aphranel® remains dedicated to inspiring beauty rooted in science across the globe.